A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Boryung Pharmaceutical Co., Ltd

ClinicalTrials.gov Identifier:

NCT01499368

First received: December 21, 2011

Last updated: January 23, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2012
Primary Completion Date:	November 2012 (Final data collection date for primary outcome measure)